Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial. - Otvos,J.D.; Collins,D.; Freedman,D.S. (Circulation, 2006)